Eton Pharmaceuticals Inc

ETONNASDAQ · US

Holders

REDUCEDT+2
Brynjelsen Sean
Eton Pharmaceuticals Inc · NASDAQ
−7,342 sh · $456.1K
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Brynjelsen Sean
Eton Pharmaceuticals Inc · NASDAQ
−47,307 sh · $2.8M
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Brynjelsen Sean
Eton Pharmaceuticals Inc · NASDAQ
−36,373 sh · $2.2M
Filed 20 Aug 2026SEC Form 4view source
REDUCEDT+2
Brynjelsen Sean
Eton Pharmaceuticals Inc · NASDAQ
−8,978 sh · $562.5K
Filed 20 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Polen Capital Management
Eton Pharmaceuticals Inc · NASDAQ
45,379 sh · $1.6M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Renaissance Technologies
Eton Pharmaceuticals Inc · NASDAQ
163,321 sh · $4.0M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDQuarterly
Two Sigma Investments
Eton Pharmaceuticals Inc · NASDAQ
106,393 sh · $2.6M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDQuarterly
Polen Capital Management
Eton Pharmaceuticals Inc · NASDAQ
30,138 sh · $743.8K
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Eton Pharmaceuticals Inc · NASDAQ
282,389 sh · $929.1K
Filed 30 Jun 2024SEC 13Fview source